A Minimalist Design Looks Great for Clearing Tau
Interception of Extracellular Tau by Antibodies May Be Sufficient to Stop the Spread of Tau in AD
Spherical Nucleic Acids Deliver a New Package for Oliognucleotide Therapeutics
SNAs Are a Hopeful First Step in Boosting the Utility of Oligonucleotides to Treat a Variety of Human Diseases
Downstream Issues Still Beset Production
To Protect the Bottom Line, Biomanufacturers Invest in Downstream Purification Technology
GEN Roundup: No Detail Is Too Small in Bioprocess Scaleup
A Change in Scale Can Change Everything
For full access to this article login to GEN Select now.
Peptide Drugs Becoming More Prevalent
Therapeutics Are Being Developed for Allergy, Asthma, Arthritis, Cancer, Diabetes, and More
- A study released by Drug and Market Development Publishing notes that peptide drugs represent a small but increasing number of pharmaceutical molecules. The report (Peptides 2006: New Applications in Discovery, Manufacturing, and Therapeutics) points out that peptide therapeutics are being developed for such disorders as allergy/asthma, arthritis, cancer, diabetes, ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.